Citadel Advisors
IGMS

Citadel Advisors’s IGM Biosciences IGMS Stock Holding History

Citadel Advisors’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,979
Closed -$21.7K – 14686
2024
Q2 		$13.6K Sell
1,979
-11,184
-85% -$95.7K ﹤0.01% 12936
2024
Q1 		$127K Sell
13,163
-198,345
-94% -$2.3M ﹤0.01% 11024
2023
Q4 		$1.76M Buy
211,508
+192,656
+1,022% +$1.12M ﹤0.01% 5596
2023
Q3 		$157K Sell
18,852
-6,302
-25% -$53.5K ﹤0.01% 10284
2023
Q2 		$232K Buy
25,154
+19,379
+336% +$217K ﹤0.01% 9559
2023
Q1 		$79.3K Sell
5,775
-14,094
-71% -$292K ﹤0.01% 11568
2022
Q4 		$338K Sell
19,869
-1,805
-8% -$36.1K ﹤0.01% 9059
2022
Q3 		$493K Sell
21,674
-2,310
-10% -$46.6K ﹤0.01% 8483
2022
Q2 		$432K Sell
23,984
-29,448
-55% -$525K ﹤0.01% 8973
2022
Q1 		$1.43M Buy
+53,432
New +$995K ﹤0.01% 6853
2021
Q4 		– Sell
-44,200
Closed -$2.2M – 14238
2021
Q3 		$2.91M Buy
+44,200
New +$3.38M ﹤0.01% 5442
2021
Q2 		– Sell
-47,514
Closed -$3.52M – 14008
2021
Q1 		$3.64M Buy
47,514
+4,655
+11% +$424K ﹤0.01% 4992
2020
Q4 		$3.78M Buy
42,859
+9,372
+28% +$659K ﹤0.01% 4171
2020
Q3 		$2.47M Buy
33,487
+10,678
+47% +$632K ﹤0.01% 4328
2020
Q2 		$1.67M Buy
22,809
+1,891
+9% +$115K ﹤0.01% 4898
2020
Q1 		$1.18M Buy
20,918
+7,192
+52% +$315K ﹤0.01% 5045
2019
Q4 		$524K Sell
13,726
-36,368
-73% -$914K ﹤0.01% 6734
2019
Q3 		$890K Buy
+50,094
New +$1.01M ﹤0.01% 5794

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors's IGMS Position: Q3 2024 in Review

Citadel Advisors sold out of IGM Biosciences (IGMS) in Q3 2024, closing a stake of 1,979 shares — an estimated $21.7K sold.

Citadel Advisors first reported a position in IGMS in Q3 2019 and held it in 18 quarters. The position peaked at $3.78M in Q4 2020. 72 funds tracked by Wall St. Rank hold IGMS as of Q3 2024.

  • Citadel Advisors reported no remaining IGM Biosciences position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 1,979 IGM Biosciences shares in Q3 2024, an estimated $21.7K.
  • Citadel Advisors first reported a position in IGM Biosciences in Q3 2019 and held it in 18 quarters.
  • Citadel Advisors's IGM Biosciences position peaked at $3.78M in Q4 2020.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.